JP2017524791A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017524791A5 JP2017524791A5 JP2017508049A JP2017508049A JP2017524791A5 JP 2017524791 A5 JP2017524791 A5 JP 2017524791A5 JP 2017508049 A JP2017508049 A JP 2017508049A JP 2017508049 A JP2017508049 A JP 2017508049A JP 2017524791 A5 JP2017524791 A5 JP 2017524791A5
- Authority
- JP
- Japan
- Prior art keywords
- controlled release
- hydrophobic
- release system
- copolymer
- block
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000002209 hydrophobic effect Effects 0.000 claims description 13
- 229920001577 copolymer Polymers 0.000 claims description 9
- 239000003814 drug Substances 0.000 claims description 6
- 239000000693 micelle Substances 0.000 claims description 6
- 229930012538 Paclitaxel Natural products 0.000 claims description 4
- 229960001592 paclitaxel Drugs 0.000 claims description 4
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical group CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims 8
- 238000013270 controlled release Methods 0.000 claims 7
- 125000003118 aryl group Chemical group 0.000 claims 6
- 229920001400 block copolymer Polymers 0.000 claims 3
- 229940124597 therapeutic agent Drugs 0.000 claims 3
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 claims 2
- 239000000032 diagnostic agent Substances 0.000 claims 2
- 229940039227 diagnostic agent Drugs 0.000 claims 2
- -1 hydroxyalkyl methacrylamide Chemical compound 0.000 claims 2
- 239000000178 monomer Substances 0.000 claims 2
- QRIMLDXJAPZHJE-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(O)CO QRIMLDXJAPZHJE-UHFFFAOYSA-N 0.000 claims 1
- OWPUOLBODXJOKH-UHFFFAOYSA-N 2,3-dihydroxypropyl prop-2-enoate Chemical compound OCC(O)COC(=O)C=C OWPUOLBODXJOKH-UHFFFAOYSA-N 0.000 claims 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 claims 1
- YSFGBPCBPNVLOK-UHFFFAOYSA-N 6-hydroxy-2-methylhex-2-enamide Chemical compound NC(=O)C(C)=CCCCO YSFGBPCBPNVLOK-UHFFFAOYSA-N 0.000 claims 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 claims 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims 1
- 229930105110 Cyclosporin A Natural products 0.000 claims 1
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 claims 1
- 108010036949 Cyclosporine Proteins 0.000 claims 1
- DWJXYEABWRJFSP-XOBRGWDASA-N DAPT Chemical compound N([C@@H](C)C(=O)N[C@H](C(=O)OC(C)(C)C)C=1C=CC=CC=1)C(=O)CC1=CC(F)=CC(F)=C1 DWJXYEABWRJFSP-XOBRGWDASA-N 0.000 claims 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 claims 1
- 239000005517 L01XE01 - Imatinib Substances 0.000 claims 1
- 239000002202 Polyethylene glycol Substances 0.000 claims 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 claims 1
- 150000001241 acetals Chemical class 0.000 claims 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 150000008064 anhydrides Chemical class 0.000 claims 1
- 229960001265 ciclosporin Drugs 0.000 claims 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 claims 1
- 229960003957 dexamethasone Drugs 0.000 claims 1
- 229960004679 doxorubicin Drugs 0.000 claims 1
- 238000011977 dual antiplatelet therapy Methods 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- VOZRXNHHFUQHIL-UHFFFAOYSA-N glycidyl methacrylate Chemical compound CC(=C)C(=O)OCC1CO1 VOZRXNHHFUQHIL-UHFFFAOYSA-N 0.000 claims 1
- KTUFNOKKBVMGRW-UHFFFAOYSA-N imatinib Chemical compound C1CN(C)CCN1CC1=CC=C(C(=O)NC=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)C=C1 KTUFNOKKBVMGRW-UHFFFAOYSA-N 0.000 claims 1
- 229960002411 imatinib Drugs 0.000 claims 1
- 125000005647 linker group Chemical group 0.000 claims 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 claims 1
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 claims 1
- 125000001624 naphthyl group Chemical group 0.000 claims 1
- 150000002905 orthoesters Chemical class 0.000 claims 1
- RPQRDASANLAFCM-UHFFFAOYSA-N oxiran-2-ylmethyl prop-2-enoate Chemical compound C=CC(=O)OCC1CO1 RPQRDASANLAFCM-UHFFFAOYSA-N 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 229920001515 polyalkylene glycol Polymers 0.000 claims 1
- 229920001223 polyethylene glycol Polymers 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 229940079593 drug Drugs 0.000 description 3
- RCHCPBMAHMWFCD-UHFFFAOYSA-N 2-hydroxypropanoic acid;n-(2-hydroxypropyl)-2-methylprop-2-enamide Chemical compound CC(O)C(O)=O.CC(O)CNC(=O)C(C)=C RCHCPBMAHMWFCD-UHFFFAOYSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 230000001687 destabilization Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL2013317 | 2014-08-11 | ||
| NL2013317A NL2013317B1 (en) | 2014-08-11 | 2014-08-11 | Amphiphilic block copolymers for delivery of active agents. |
| PCT/NL2015/050574 WO2016024861A1 (en) | 2014-08-11 | 2015-08-11 | Amphiphilic block copolymers for delivery of active agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017524791A JP2017524791A (ja) | 2017-08-31 |
| JP2017524791A5 true JP2017524791A5 (enExample) | 2020-01-09 |
| JP6837962B2 JP6837962B2 (ja) | 2021-03-03 |
Family
ID=51660570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017508049A Active JP6837962B2 (ja) | 2014-08-11 | 2015-08-11 | 活性薬剤の送達のための両親媒性ブロックコポリマー |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11007148B2 (enExample) |
| EP (1) | EP3191534B1 (enExample) |
| JP (1) | JP6837962B2 (enExample) |
| CN (1) | CN107106693B (enExample) |
| AU (1) | AU2015302410B2 (enExample) |
| CA (1) | CA2957900C (enExample) |
| NL (1) | NL2013317B1 (enExample) |
| WO (1) | WO2016024861A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4175966A1 (en) | 2020-07-06 | 2023-05-10 | Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen | Polymeric micelles comprising glucuronide-prodrugs |
| WO2023044389A1 (en) | 2021-09-15 | 2023-03-23 | Gelmedix, Inc. | Gelma polymer compositions comprising corticosteroids |
| IL311339A (en) | 2021-09-15 | 2024-05-01 | Gelmedix Inc | Gelma polymer compositions and uses thereof |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7425581B2 (en) * | 1999-07-30 | 2008-09-16 | Universiteit Utrecht | Temperature sensitive polymers |
| US7217770B2 (en) * | 2000-05-17 | 2007-05-15 | Samyang Corporation | Stable polymeric micelle-type drug composition and method for the preparation thereof |
| US20050158271A1 (en) * | 2000-10-11 | 2005-07-21 | Lee Sang C. | Pharmaceutical applications of hydrotropic polymer micelles |
| US6939564B2 (en) | 2001-06-08 | 2005-09-06 | Labopharm, Inc. | Water-soluble stabilized self-assembled polyelectrolytes |
| GB0131112D0 (en) | 2001-12-31 | 2002-02-13 | Univ London Pharmacy | Block copolymers |
| JP2011515504A (ja) | 2008-01-25 | 2011-05-19 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー | ニッケルまたはニッケル合金を含むインクジェットプリントヘッドに用いる改善された耐食性を有するインクジェットインク |
| US20110281934A1 (en) * | 2008-11-06 | 2011-11-17 | Phaserx, Inc. | Micelles of hydrophilically shielded membrane-destabilizing copolymers |
| US8299178B2 (en) * | 2009-03-25 | 2012-10-30 | National Tsing Hua University | Stable micelles formed with diblock copolymers of critical micelle concentration copolymer and temperature-sensitive copolymer |
| JP5679253B2 (ja) * | 2009-05-26 | 2015-03-04 | 国立大学法人東京工業大学 | 自立性高分子薄膜 |
| US8470891B2 (en) | 2009-12-23 | 2013-06-25 | International Business Machines Corporation | Biodegradable block polymers for drug delivery, and methods related thereto |
| JP5864837B2 (ja) * | 2010-03-24 | 2016-02-17 | セイコーエプソン株式会社 | 光重合性ポリマーミセルを含む記録液、及び記録液に用いる光重合性ポリマーミセルの製造方法 |
| ES2391187B1 (es) * | 2011-04-26 | 2013-10-18 | Consejo Superior De Investigaciones Científicas (Csic) | Compuestos poliméricos bioactivos nanoestructurados derivados de fármacos antiinflamatorios no esteroideos (aine) e imidazol. |
| ES1075003Y (es) * | 2011-06-16 | 2011-10-10 | Antimo Juan Manuel Cuartero | Recuperador de calor |
-
2014
- 2014-08-11 NL NL2013317A patent/NL2013317B1/en not_active IP Right Cessation
-
2015
- 2015-08-11 JP JP2017508049A patent/JP6837962B2/ja active Active
- 2015-08-11 CN CN201580053545.1A patent/CN107106693B/zh active Active
- 2015-08-11 US US15/503,204 patent/US11007148B2/en active Active
- 2015-08-11 WO PCT/NL2015/050574 patent/WO2016024861A1/en not_active Ceased
- 2015-08-11 AU AU2015302410A patent/AU2015302410B2/en active Active
- 2015-08-11 EP EP15767355.9A patent/EP3191534B1/en active Active
- 2015-08-11 CA CA2957900A patent/CA2957900C/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2006315238B2 (en) | Injectable formulation capable of forming a drug-releasing device | |
| CN105916495B (zh) | 聚合物颗粒 | |
| Ahmed et al. | The effect of polymer architecture, composition, and molecular weight on the properties of glycopolymer-based non-viral gene delivery systems | |
| McCaffrey et al. | Transcending epithelial and intracellular biological barriers; a prototype DNA delivery device | |
| Tang et al. | Physical hydrogels with self-assembled nanostructures as drug delivery systems | |
| Han et al. | Effects of hydrophobic core components in amphiphilic PDMAEMA nanoparticles on siRNA delivery | |
| CN105722494B (zh) | 抗冲改性的义齿基托组合物 | |
| AR103981A1 (es) | Métodos y composiciones particularmente para el tratamiento del trastorno por déficit de atención | |
| ES2679195T3 (es) | Método para la preparación de un sistema de liberación controlada | |
| JP2018502956A5 (enExample) | ||
| Merkel et al. | Quo vadis polyplex? | |
| RS66643B1 (sr) | Farmaceutska kompozicija | |
| JP2015120756A5 (enExample) | ||
| Truong et al. | Overcoming surfactant-induced morphology instability of noncrosslinked diblock copolymer nano-objects obtained by RAFT emulsion polymerization | |
| WO2010061288A3 (en) | Polymeric pharmaceutical dosage form in sustained release | |
| RU2014101228A (ru) | Покрывающая композиция, подходящая для фармацевтических или нутрицевтических лекарственных форм | |
| RU2018105494A (ru) | Улучшенные системы доставки наночастиц | |
| Erdemli et al. | In vitro evaluation of effects of sustained anti-TNF release from MPEG-PCL-MPEG and PCL microspheres on human rheumatoid arthritis synoviocytes | |
| JP2008522989A5 (enExample) | ||
| JP2015143256A5 (enExample) | ||
| JP2022514956A5 (enExample) | ||
| Constantinou et al. | PEG-based methacrylate tetrablock terpolymers: how does the architecture control the gelation? | |
| TR201820076T4 (tr) | İlaç kombinasyonlarının salımı. | |
| Singh et al. | Hydrogel as a novel drug delivery system: Recent advancements and patents | |
| Moroishi et al. | A free-standing, sheet-shaped,“hydrophobic” biomaterial containing polymeric micelles formed from poly (ethylene glycol)-poly (lactic acid) block copolymer for possible incorporation/release of “hydrophilic” compounds |